Volpara (ASX:VHT) share price charges higher on Q2 update

It's been a good day so far for Volpara shares…

| More on:
four excited doctors with their hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volpara Health Technologies Ltd (ASX: VHT) share price is on the move on Wednesday morning.

At the time of writing, the healthcare technology company's shares are up 3% to $1.17.

Why is the Volpara share price rising?

Investors have been bidding the Volpara share price higher today after the release of second quarter business update.

According to the release, the company was on form during the three months and delivered record quarterly growth in net new annual recurring revenue (ARR). Volpara added US$1.2 million during what is traditionally its slowest quarter.

This means that Volpara's ARR has now reached ~US$20.4 million (~NZ$29.0 million), which is up ~10% since the end of FY 2021.

In respect to market share, the company estimates that it now has at least one software product contracted to be used in the breast cancer screening of approximately 34% of US women. This equates to approximately 13.4 million women and is up from 33% at the end of the first quarter.

Also heading in the right direction is its Average Revenue per User (ARPU). It was US$2.04 for the quarter and is now US$1.46 over the entire installed base. This is up from US$1.42 in the first quarter.

The company also notes that it has just announced its largest contract to date. It estimates that it will deliver US$2.15 million in revenue over five years, which represents US$430,000 in ARR.

Management notes that its result and new contract reflects its customers' desire to facilitate personalised breast cancer care with tightly integrated breast density, cancer risk, and patient reporting.

Management commentary

Volpara's CEO, Dr Ralph Highnam, commented: "Volpara has had a tremendously strong quarter despite the continuing challenges of the COVID-19 pandemic. The Volpara Health Breast Platform is gaining momentum as clinics begin to understand the power of a fully integrated patient tracking, risk, and density offering."

"We also saw a number of large Analytics deals signed and are pleased with the continually improving ARPU as we land new customers with our larger suite of products or expand with existing customers continuing to grow with us. Promisingly, we enter Q3 with a strong pipeline and look forward to showing off our outstanding product platform at RSNA, the world's largest radiology trade show, in early December," he added.

The Volpara share price is down 17.5% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »